| Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures H Warsinske, R Vashisht, P Khatri PLoS medicine 16 (4), e1002786, 2019 | 161 | 2019 |
| Identification of antiviral antihistamines for COVID-19 repurposing LR Reznikov, MH Norris, R Vashisht, AP Bluhm, D Li, YSJ Liao, A Brown, ... Biochemical and biophysical research communications 538, 173-179, 2021 | 118 | 2021 |
| Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with … R Vashisht, K Jung, A Schuler, JM Banda, RW Park, S Jin, L Li, JT Dudley, ... JAMA network open 1 (4), e181755-e181755, 2018 | 83 | 2018 |
| Metformin as a potential combination therapy with existing front-line antibiotics for tuberculosis R Vashisht, SK Brahmachari Journal of translational medicine 13, 1-3, 2015 | 81 | 2015 |
| Crowd Sourcing a New Paradigm for Interactome Driven Drug Target Identification in Mycobacterium tuberculosis R Vashisht, AK Mondal, A Jain, A Shah, P Vishnoi, P Priyadarshini, ... PloS one 7 (7), e39808, 2012 | 49 | 2012 |
| Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis K Raman, R Vashisht, N Chandra Molecular BioSystems 5 (12), 1740-1751, 2009 | 42 | 2009 |
| Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis Y Kim, Y Tian, J Yang, V Huser, P Jin, CG Lambert, H Park, SC You, ... Scientific Reports 10 (1), 11115, 2020 | 35 | 2020 |
| Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network Q Wang, JM Reps, KF Kostka, PB Ryan, Y Zou, EA Voss, PR Rijnbeek, ... PLoS One 15 (1), e0226718, 2020 | 33 | 2020 |
| Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets R Vashisht, AG Bhat, S Kushwaha, A Bhardwaj, O Consortium, ... Journal of Translational Medicine 12, 1-19, 2014 | 32 | 2014 |
| Impact of integrated psycho-socio-economic support on treatment outcome in drug resistant tuberculosis–A retrospective cohort study R Bhatt, K Chopra, R Vashisht Indian Journal of Tuberculosis 66 (1), 105-110, 2019 | 31 | 2019 |
| Protein–protein interaction networks suggest different targets have different propensities for triggering drug resistance J Padiadpu, R Vashisht, N Chandra Systems and synthetic biology 4, 311-322, 2010 | 27 | 2010 |
| Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry DH Kwon, R Vashisht, HT Borno, RR Aggarwal, EJ Small, AJ Butte, ... Annals of Oncology 32 (5), 678-679, 2021 | 19 | 2021 |
| CovidCounties is an interactive real time tracker of the COVID19 pandemic at the level of US counties D Arneson, M Elliott, A Mosenia, B Oskotsky, S Solodar, R Vashisht, ... Scientific data 7 (1), 405, 2020 | 19 | 2020 |
| Treatment patterns for chronic comorbid conditions in patients with cancer using a large-scale observational data network R Chen, P Ryan, K Natarajan, T Falconer, KD Crew, CG Reich, ... JCO clinical cancer informatics 4, 171-183, 2020 | 18 | 2020 |
| Age-and sex-associated variations in the sensitivity of serological tests among individuals infected with SARS-CoV-2 R Vashisht, A Patel, BO Crews, OB Garner, L Dahm, C Wilson, AJ Butte JAMA Network Open 4 (2), e210337-e210337, 2021 | 14 | 2021 |
| Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid AG Bhat, R Vashisht, N Chandra Systems and synthetic biology 4, 299-309, 2010 | 14 | 2010 |
| Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational … EA Voss, A Shoaibi, LYH Lai, C Blacketer, T Alshammari, R Makadia, ... EClinicalMedicine 58, 2023 | 12 | 2023 |
| Learning effective treatment pathways for type-2 diabetes from a clinical data warehouse R Vashisht, K Jung, N Shah AMIA Annual Symposium Proceedings 2016, 2036, 2017 | 12 | 2017 |
| Social networks to biological networks: systems biology of Mycobacterium tuberculosis R Vashisht, A Bhardwaj, SK Brahmachari, Osdd Consortium Molecular bioSystems 9 (7), 1584-1593, 2013 | 11 | 2013 |
| Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing BY Miao, M Sushil, A Xu, M Wang, D Arneson, E Berkley, M Subash, ... The Lancet Digital Health 6 (3), e222-e229, 2024 | 9 | 2024 |
Atul J. ButteDirector, Bakar Computational Health Sciences Institute, University of California, San FranciscoVerified email at ucsf.edu